Annual Translational Microbiome Conference 2016

Arrowhead Publishers is pleased to announce its 2nd Annual Translational Microbiome Conference will be held April 20-21, 2016 in Boston. This conference will focus on the potential for translational interventions in microbiome research and the challenges the industry will need to address to make this space successful. Preclinical and clinical research will be the focus of the 2016 Conference. Therapeutic areas of research with potential for actionable interventions to be covered at this conference include women's health, obesity and type 2 diabetes, pulmonology and COPD, immunology, C. diffiicle infections, dermatology, periodontal disease and others. Research into the microbiome is still in its infancy and yet has already revealed its potential role in a host of diseases, including obesity, Type 2 diabetes, inflammatory bowel diseases, preterm birth and Urinary Tract Infections (UTIs), as well as numerous connections between the oral microbiome and systemic diseases such as rheumatoid arthritis, cardiac disease and pancreatic cancer. Reflective of the microbiome’s potential as “the most exciting frontier in medicine,” according to Francis Collins, Director, NIH, are the numerous collaborative research projects underway, such as the Integrative Human Microbiome Project Research Consortium and the Human Microbiome Project, as well as any number of consortia at research institutions as Stanford, Arizona State University and others. Research in the microbiome presents a potential opportunity to provide significant preventative treatments, cures, therapies and supplements – with few or no adverse events – for a worldwide audience. Reflective of this trend is the fact that investment opportunities are growing in this area and many companies are rapidly moving towards potential translational work and the introduction of commercial ventures. But there are numerous challenges and hurdles to be overcome before that value can be fully